VAERS reports by lot

GSK Varicella/Shingles lot T79D7: VAERS reports

25 VAERS reports list lot T79D7 as a GSK Varicella/Shingles vaccine, received between 2020-10-26 and 2023-01-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
8%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2129%
Injection-site / Local reaction1926%
Dermatological (non-injection-site)1014%
Neurological912%
Gastrointestinal68%
Musculoskeletal46%
Cardiac / Cardiovascular23%
Allergic / Anaphylactic11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania4
North Carolina3
Minnesota3
Delaware1
Missouri1
New Jersey1
Nevada1
Alabama1
Ohio1
Illinois1
Maine1
New York1

Reports by month received

2020-101
2020-116
2020-128
2021-013
2021-023
2021-091
2021-101
2023-012

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.